Product Royalty shall have the meaning provided in Section 4.7.
Product Royalty has the meaning set forth in Section 9.6.
Product Royalty means a royalty payment made by the GRANTEE to the GRANTOR on the products or services sold by GRANTEE in the Territory, which utilize the GRANTOR’s hardware, mobile VoIP software, business model or technology.
Examples of Product Royalty in a sentence
This Agreement shall become effective on the Effective Date and, unless earlier terminated pursuant to this Article 5, shall remain in effect until the expiration of the last Product Royalty Term in the Territory (the “Term”).
If a Biosimilar Product to a Product is sold in any country in the Territory during the Product Royalty Term for such Product and country, the Product Royalties payable with respect to such Product in such country will be reduced by [***] for the remainder of such Product Royalty Term.
Following expiration of the Product Royalty Term for any Product in a given country, no further Product Royalties shall be payable for such Product in such country, and the Product License granted to Artiva under Section 2.1 with respect to such Product in such country shall automatically become fully paid-up, perpetual and royalty-free and shall survive any expiration or termination of this Agreement.
Artiva shall pay to GCLC royalties on Net Sales of Products, the manufacture, use or sale of which are claimed by or use any Product Technology, on a country-by-country and Product-by-Product basis during the Product Royalty Term, as calculated by multiplying the applicable portion of aggregate Net Sales of the Product in the Territory by the corresponding royalty rate, as set forth in the table below, subject to the applicable adjustments in accordance with Section 3.2(e) below (the “Product Royalties”).
The Product Royalty will be payable on a Product-by-Product and country-by-country basis from First Commercial Sale of such Product in such country until (i) such Product is no longer Covered by a Valid Patent Claim in such country or (ii) ten (10) years after the First Commercial Sale of such Product in such country, whichever is later (the “Product Royalty Term”).
More Definitions of Product Royalty
Product Royalty means a royalty payment made by the XIAM to the MLSC on the products assembled or manufacture and sold by XIAM in the Territory, which utilize software developed solely by Stroke’s. The Product Royalty has been established at $4.00 net per unit for all units manufacture and sold by XIAM in the Territory.
Product Royalty. Licensor shall receive five percent (5%) Royalty Fee, of Net True 2 Life Products sales outside of the True 2 Life Distributor Network, that is to anyone that is not now or in the future in the True 2 Life Distributor Group. This Royalty will be paid for 48 months, 2% for the next 36 months (a total of 84 Royalty Payments) in additional to the 10% Royalty Fee calculated and paid of the True2Life Distributor Organization sales. Example: Months 1-48 are to be t:alculated at 5% Months 49-84 are to be calculated at 2%
Product Royalty means a royalty payment made by LICENSEE and/or SUB-LICENSEE(S) to LICENSOR on the products actually sold, rented or leased by LICENSEE or SUB-LICENSEE(S) and paid for by customers of the LICENSEE OR SUB-LICENSEE(S). The ROYALTY shall be FIVE PERCENT (5%) of the NET SELLING PRICE, of all products sold, rented or leased directly by LICENSEE and paid for by customers of LICENSEE. The ROYALTY shall be reduced to THREE PERCENT (3%) of the NET SELLING PRICE, of all products sold, rented or leased by any SUB-LICENSEE and paid for by customers of SUB-LICENSEE. LICENSEE and SUB-LICENSEE(S) shall be credited with ROYALTIES previously paid on LICENSED PRODUCT returned from previous sales of LICENSED PRODUCT.
Product Royalty means a royalty payment made by the GRANTEE to the GRANTOR on the products assembled or manufacture and sold by GRANTEE in the Territory, which utilize the GRANTOR's components or technology. 2.17 "Trademarks" means all registered and unregistered trademarks, service marks, trade names, business names, brand names, product names and any other indicators of origin, whether registered or unregistered, belonging to either Party. 2.18 "The Exclusive License" means the right, to the exclusion of any other entity including GRANTOR, for GRANTEE within the Territory to: Purchase and import the Products and component parts of Products from GRANTOR or an entity approved of by GRANTOR, to market, distribute and sell, the assembly or manufacture according the defined conditions, for installation, application and maintenance of the Products in the name of GRANTEE or any related body corporate. 2.19 "The Non- Exclusive License" means the right, to the non- exclusion of any other entity including GRANTOR, for GRANTEE within the Territory to: Purchase and import the Products and component parts of Products from GRANTOR or an entity approved of by GRANTOR, to market, distribute and sell, the assembly or manufacture according the defined conditions, for installation, application and maintenance of the Products in the name of GRANTEE or any related body corporate. 3. GRANT OF MARKETING RIGHTS 3.1 GRANTOR hereby grants to GRANTEE the right to sell finished units in the Territory in all markets but the dental market on an exclusive basis for a period of two years, subject to obtaining independent certification and verification as outline in the Water Treatment Standard 61, completing ETV testing by NSF International, Inc., and approval of the United States Environmental Protection Agency, as defined in Appendix A attached hereto. As a condition of the granting of this License, the Grantee agrees to undertake the filing of a joint submission in the name of both the GRANTOR and GRANTEE with the intention of having the GRANTOR being able to utilize any approval to enhance its credibility in all markets outside the Territory defined in this agreement. At the end of each business year, beginning with calendar year three after the effective date of this agreement, if the GRANTEE has satisfied the defined objectives of sales defined in table 1 of Appendix B of this Agreement, the GRANTEE will have the right to continue to sell finished AO Units on an exclusive basis in the territory....
Product Royalty. The Licensed Product Royalty shall be calculated and paid on a monthly basis for receipt by Lactoferrin on or before the last day of each month. The Royalty Due means the greater of (1) the Per Unit Royalty or (2) the Minimum Royalty, as the case may be. Whenever a Contract Years Minimum Royalty has been paid, there will be no further Minimum Royalty for that year. After the Minimum Royalty has been paid for such Contract Year, Mannatech shall only pay for sale of any Licensed Product or Products as per the terms above and at the rate of the Per Unit Royalty below.
Product Royalty has the meaning set forth in Section 8.4.1. “Prosecution and Maintenance” or “Prosecute and Maintain” means, with regard to a particular Patent, the preparation, filing, prosecution and maintenance of such Patent, as well as all proceedings that may take place before the patent office in any given country or territory, including but not limited to U.S. interferences, U.S. inter partes reviews and EP oppositions. For avoidance of doubt, “Prosecution and Maintenance” or “Prosecute and Maintain” will not include any actions taken with respect to a Patent under Section 9.6 or Section 9.7. “Publishing Party” has the meaning set forth in Section 10.2.1. “Receiving Party” has the meaning set forth in Section 10.1.1. “Regulatory Authority” means any Governmental Authority involved in granting approvals for Development, Manufacturing or Commercialization, including the FDA, the EMA, the Japanese Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency in Japan. “Regulatory Exclusivity” means any exclusive marketing rights or data exclusivity rights conferred by any applicable Governmental Authority or Regulatory Authority, other than an issued and unexpired Patent, including any regulatory data protection exclusivity (including, where applicable, pediatric exclusivity and/or orphan drug exclusivity) and/or any other exclusivity afforded by restrictions which prevent the granting by a Regulatory Authority of regulatory approval to market a Biosimilar. “Regulatory Materials” means regulatory applications, submissions, dossiers, notifications, registrations, case report forms, trial master file, drug master file (“DMF”), common technical documents, question and answers with Regulatory Authorities, Marketing Approvals or other filings or communications made to or with, or other approvals granted by, a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize a Product in a particular country or regulatory jurisdiction. “Research” or “Researching” means activities, other than Development, related to the design, discovery, generation, identification, profiling, characterization, production, process development, cell line development, pre-clinical development or non-clinical or pre-clinical studies of drug candidates and Product.
Product Royalty is defined in Section 2.3.1.